The Indiana University School of Medicine has been awarded a one-year, $7.6 million grant from the National Institute on Aging to study early-onset Alzheimer’s disease.
Early-onset patients are commonly excluded from clinical research and therapeutic trials because of their young age or lack of memory loss. Approximately 5 percent of Alzheimer’s patients develop symptoms before age 65, with less than 10 percent of these patients carrying known mutations for the disease, IU said.
The grant will help begin recruitment for what will be an approximately $45 million research program led by Dr. Liana G. Apostolova, professor of Alzheimer’s disease research at the IU School of Medicine.•
Please enable JavaScript to view this content.